113. Muscular dystrophy Clinical trials / Disease details


Clinical trials : 622 Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00451074
(ClinicalTrials.gov)
March 200721/3/2007Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop CodonsA Six Month Randomized, Clinical Trial of Gentamicin in Duchenne Muscular Dystrophy Subjects With Stop Codon MutationsDuchenne Muscular DystrophyDrug: Gentamicin infusions twice a week for six monthsNationwide Children's HospitalNational Institutes of Health (NIH);National Institute of Neurological Disorders and Stroke (NINDS)Completed5 Years20 YearsMale12Phase 1United States
2NCT00005574
(ClinicalTrials.gov)
February 20002/5/2000Gentamicin Treatment of Muscular DystrophyGentamicin Treatment of Patients With Muscular Dystrophy Due to Nonsense Mutations in DystrophinBecker Muscular Dystrophy;Duchenne Muscular DystrophyDrug: GentamicinNational Institute of Neurological Disorders and Stroke (NINDS)NULLCompletedN/AN/ABoth4Phase 1United States